Communication
Organic & Biomolecular Chemistry
Acknowledgements
This work was supported by the National Research Foundation
of Korea (NRF-2016R1D1A3B03931686 to C. M. P) and by the
research grant of the Gangneung-Wonju National University in
2017.
Notes and references
1 R. Wang, Physiol. Rev., 2012, 92, 791–896.
2 C. Szabo, Nat. Rev. Drug Discovery, 2007, 6, 917–935.
3 M. Whiteman, S. Le Trionnaire, M. Chopra, B. Fox and
J. Whatmore, Clin. Sci., 2011, 121, 459–488.
4 B. D. Paul and S. H. Snyder, Nat. Rev. Mol. Cell Biol., 2012,
13, 499–507.
Fig. 4 Effect of the different H2S donors on the cell viability of H9c2
cells. The cells were treated with various concentrations of 3b, 3c, and
NaHS for 24 h. The cell counting kit-8 (CCK-8) assay was performed to
measure the cell viability. The significant difference versus vehicle (***p
< 0.001, **P < 0.01, *P < 0.05, n = 4).
5 O. Kabil and R. Banerjee, Antioxid. Redox Signal., 2014, 20,
770–782.
6 H. Kimura, Amino Acids, 2011, 41, 113–121.
7 B. L. Predmore, D. J. Lefer and G. Gojon, Antioxid. Redox
Signal., 2012, 17, 119–140.
8 K. R. Olson, Antioxid. Redox Signal., 2012, 17, 32–44.
9 C. Jacob, A. Anwar and T. Burkholz, Planta Med., 2008, 74,
1580–1592.
10 J. L. Wallace and R. Wang, Nat. Rev. Drug Discovery, 2015,
14, 329–345.
11 D. J. Polhemus and D. J. Lefer, Circ. Res., 2014, 114, 730–737.
12 W. Zhao, J. Zhang, Y. Lu and R. Wang, EMBO J., 2001, 20,
6008–6016.
13 J. W. Calvert, W. A. Coetzee and D. J. Lefer, Antioxid. Redox
Signal., 2010, 12, 1203–1217.
path a. Based on this mechanistic study, we therefore assumed
that 3b produces about twice the quantity of H2S compared to
3c due to the presence of two benzoate groups in its structure.
This is consistent with the H2S measurements presented in
Fig. 2.
Finally, we tested the H9c2 cell viability upon treatment
with donors 3b and 3c to understand trithiane-based cellular
cytotoxicity of the donors. For this purpose, sodium hydrogen
sulfide (NaHS) was used as a control. Thus, the cells were
treated with 10, 25, 50, 100, and 200 µM of each donor for
24 h, after which time the cell viability was determined using
the cell counting kit-8 (CCK-8) assay. As shown in Fig. 4,
neither 3b or 3c, nor NaHS exhibited any significant cellular
toxicity to H9c2 cells at these doses.
14 B. L. Predmore and D. J. Lefer, Expert Rev. Clin. Pharmacol.,
2011, 4, 83–96.
15 J. L. Wallace, L. Vong, W. McKnight, M. Dicay and
G. R. Martin, Gastroenterology, 2009, 137, 569–578.
16 K. R. Olson, R. A. Dombkowski, M. J. Russell,
M. M. Doellman, S. K. Head, N. L. Whitfield and
J. A. Madden, J. Exp. Biol., 2006, 209, 4011–4023.
17 A. Tangerman, J. Chromatogr., B: Anal. Technol. Biomed. Life
Sci., 2009, 877, 3366–3377.
Conclusions
In conclusion, we herein report the design and synthesis of
trithiane-based H2S donors that release H2S following esterase-
triggered hydrolysis. As a result of our evaluation of the H2S
releasing capabilities of these donors using fluorescence-
based methods, we concluded that the structure containing
two benzoate groups produced about twice the quantity of H2S
compared to an analogous structure containing only one ben-
zoate group. Furthermore, following exploration of the H2S
release mechanism by GC-MS analysis, carbonothionic acid
and thioformic acid were identified as the hydrolysis products
for the donor containing two ester groups. These two com-
pounds then undergo further hydrolysis to afford H2S. In con-
trast, the donor containing a single ester group produced only
carbonothionic acid. Studies are now ongoing in our group to
determine the effects of these donors on various disease
models.
18 O. Kabil and R. Banerjee, J. Biol. Chem., 2010, 285, 21903–
21907.
19 R. C. Zanardo, V. Brancaleone, E. Distrutti, S. Fiorucci,
G. Cirino, J. L. Wallace, R. C. Zanardo, V. Brancaleone,
E. Distrutti and S. Fiorucci, FASEB J., 2006, 20, 2118–2120.
20 R. Tamizhselvi, P. K. Moore and M. Bhatia, Pancreas, 2008,
36, e24–e31.
21 G. A. Benavides, G. L. Squadrito, R. W. Mills, H. D. Patel,
T. S. Isbell, R. P. Patel, V. M. Darley-Usmar, J. E. Doeller
and D. W. Kraus, Proc. Natl. Acad. Sci. U. S. A., 2007, 104,
17977–17982.
22 Y. Zhao, H. Wang and M. Xian, J. Am. Chem. Soc., 2011,
133, 15–17.
23 L. Li, M. Whiteman, Y. Y. Guan, K. L. Neo, Y. Cheng,
S. W. Lee, Y. Zhao, R. Baskar, C.-H. Tan and P. K. Moore,
Circulation, 2008, 117, 2351–2360.
Conflicts of interest
There are no conflicts to declare.
10002 | Org. Biomol. Chem., 2019, 17, 9999–10003
This journal is © The Royal Society of Chemistry 2019